Security key
47103J105
Janux Therapeutics, Inc. - Common Stock (JANX)
CUSIP: 47103J105
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 45,621,730
- Total 13F value
- $2,072,353,785
- Share change
- +819,630
- Put/Call ratio
- 766%
- SEC-reported price per share
- $45.43
- Number of holders
- 158
- Value change
- +$42,332,014
- Number of buys
- 85
- Number of sells
- 76
- Shares outstanding
- 60,817,522
Holder snapshot
7 facts
Show 1 more fact
Security identity
1 fact
Report period
Q3 2024
Institutions
158
Top holders
10
JANX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2024
Previous quarter: Q2 2024
Janux Therapeutics, Inc. SEC filings
Janux Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 47103J105
Recent filing periods:
Ownership snapshot
Top reported holders of JANX - Janux Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
RA CAPITAL MANAGEMENT, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
15/15
Latest evidence
30 Jun 2024
13F
3/4/5
Lead comparable stake: 15%
Showing 1-6 of 15 holder rows.
Quick read
RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 15%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
RA CAPITAL MANAGEMENT, L.P.
15%
FMR LLC
13%
ORBIMED ADVISORS LLC
4.9%
BlackRock Finance, Inc.
3.9%
ADAGE CAPITAL PARTNERS GP, L.L.C.
3.8%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
Company
|
15%
|
$383,949,162
9,165,652 shares
|
— | 30 Jun 2024 |
| FMR LLC |
13F
Company
|
13%
|
$325,803,649
7,777,600 shares
|
— | 30 Jun 2024 |
| ORBIMED ADVISORS LLC |
13F
3/4/5
Company · Director
|
4.9%
|
$124,824,995
2,979,828 shares
|
— | 30 Jun 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
3.9%
|
$98,190,453
2,344,007 shares
|
— | 30 Jun 2024 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
Company
|
3.8%
|
$97,515,563
2,327,896 shares
|
— | 30 Jun 2024 |
| JANUS HENDERSON GROUP PLC |
13F
Company
|
3%
|
$75,389,599
1,801,843 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
158
Shares
45,621,730
Rows available
158
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
153
Q3 2024 holders
158
Holder diff
5
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend